The role of PPAR-γ in macrophage differentiation and cholesterol uptake

被引:447
作者
Moore, KJ
Rosen, ED
Fitzgerald, ML
Randow, F
Andersson, LP
Altshuler, D
Milstone, DS
Mortensen, RM
Spiegelman, BM
Freeman, MW [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Lipid Metab Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[5] MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02139 USA
[6] Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA
[7] Univ Michigan, Dept Physiol, Div Endocrine, Ann Arbor, MI 48109 USA
关键词
D O I
10.1038/83328
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma), the transcription factor target of the anti-diabetic thiazolidinedione (TZD) drugs, is reported to mediate macrophage differentiation and inflammatory responses. Using PPAR-gamma -deficient stem cells, we demonstrate that PPAR-gamma is neither essential for myeloid development, nor for such mature macrophage functions as phagocytosis and inflammatory cytokine production. PPAR-gamma is required for basal expression of CD36, but not for expression of the other major scavenger receptor responsible for uptake of modified lipoproteins, SR-A. In wild-type macrophages, TZD treatment divergently regulated CD36 and class A macrophage-scavenger receptor expression and failed to induce significant cellular cholesterol accumulation, indicating that TZDs may not exacerbate macrophage foam-cell formation.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 47 条
[1]   Structural and functional characterization of the human CD36 gene promoter - Identification of a proximal PEBP2/CBF site [J].
Armesilla, AL ;
Calvo, D ;
Vega, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7781-7787
[2]  
ASHKENAS J, 1993, J LIPID RES, V34, P983
[3]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[4]  
Calvo D, 1998, J LIPID RES, V39, P777
[5]   CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors [J].
Chinetti, G ;
Gbaguidi, FG ;
Griglio, S ;
Mallat, Z ;
Antonucci, M ;
Poulain, P ;
Chapman, J ;
Fruchart, JC ;
Tedgui, A ;
Najib-Fruchart, J ;
Staels, B .
CIRCULATION, 2000, 101 (20) :2411-2417
[6]   The nuclear receptor PPARγ and immunoregulation:: PPARγ mediates inhibition of helper T cell responses [J].
Clark, RB ;
Bishop-Bailey, D ;
Estrada-Hernandez, T ;
Hla, T ;
Puddington, L ;
Padula, SJ .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1364-1371
[7]   MACROPHAGE-COLONY-STIMULATING FACTOR SELECTIVELY ENHANCES MACROPHAGE SCAVENGER RECEPTOR EXPRESSION AND FUNCTION [J].
DEVILLIERS, WJS ;
FRASER, IP ;
HUGHES, DA ;
DOYLE, AG ;
GORDON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :705-709
[8]   A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism [J].
Febbraio, M ;
Abumrad, NA ;
Hajjar, DP ;
Sharma, K ;
Cheng, WL ;
Pearce, SFA ;
Silverstein, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19055-19062
[9]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[10]  
Feng JW, 2000, J LIPID RES, V41, P688